Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Heather L. Wamsley
Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis Throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans
PLoS ONE
Multidisciplinary
Related publications
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Cells
JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms
PLoS ONE
Multidisciplinary
Cancer Gene Profiling in Non-Small Cell Lung Cancers Reveals Activating Mutations in JAK2 and JAK3 With Therapeutic Implications
Genome Medicine
Molecular Medicine
Genetics
Molecular Biology
Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice
Molecular and Cellular Biology
Cell Biology
Molecular Biology
JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes
International Journal of Toxicology
Toxicology
JAK2 Mutation Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients
Folia Histochemica et Cytobiologica
Medicine
Forensic Medicine
Pathology
Histology
Dual Inhibition of Jak2 and STAT5 Enhances Killing of Myeloproliferative Neoplasia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Therapeutic Potential of JAK2 Inhibitors
The Journal of OncoPathology
Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis
Blood
Biochemistry
Immunology
Cell Biology
Hematology